News

We have now reached 245 participants randomised and 303 participants screened meaning we have recruited 65% of our goal for analysis stage 1 (375)!

So far:

• 13 hospital sites are open and actively contacting potential participants.
• 413 potential participants have been through telephone screening by their chosen site.
• 296 have attended their chosen hospital site for further screening and to give consent.
• 241 participants have entered the Octopus trial and started trial treatment.
• Another 134 participants will start treatment on the Octopus trial by December 2024 – to reach the goal of 375 participants in this first stage of the trial.

Read this short news update on how the Octopus trial team and MS Society have partnered up to work on programmes to consider ways we can increase diversity in clinical trials.

A member of the BBC Southampton team was interviewed by BBC Solent radio and BBC News published an article where they spoke to Dr Ian Galea (lead consultant for Octopus in Southampton) and one of the participants.